Brad Amos, MD, PhD, FAAD
Board-Certified Dermatologist
4.9 /5
417 reviews
Survey
4.0/5
Forefront Dermatology
Staff & Dr Amos is very nice
Survey
5.0/5
Forefront Dermatology
Very satisfied would not go anywhere else Entire experience went smoothly from the front desk to check out
Survey
5.0/5
Forefront Dermatology
I appreciated how they worked with me to get another appointment time after I missed my earlier one that day.
Survey
5.0/5
Forefront Dermatology
Dr. Amos is always a pleasure to see.
Survey
5.0/5
Forefront Dermatology
Very good experience.
Survey
5.0/5
Forefront Dermatology
I give Dr. Amos a 5 star rating - this site didn’t take the “click” on the star however. The visit was fast, efficient and thorough. Dr. Amos was kind, considerate and respectful.
Survey
5.0/5
Forefront Dermatology
I always enjoy chatting with Dr. Amos on my visits! The care is also first rate by the way!!!
Survey
5.0/5
Survey Forefront Dermatology
When I am in Dr. Amos office, I feel very comfortable and know I am able to ask any conceivable question and he or his staff are very good on answering all those questions. He is like a friend.
Survey
5.0/5
Forefront Dermatology
I had a great experience overall.The wait time to see the doctor was short,and he explained everything in terms I could understand.He took the time to answer all of my questions.
Survey
5.0/5
Survey Forefront Dermatology
Dr. Amos is the best. Very knowledgeable and devotes as much time as needed. Friendly makes for a pleasant visit.
Education

Undergraduate Degree:

BS, University of Pittsburgh – Pittsburgh, PA

Doctorate Degree:

PhD, University of Texas – Houston, TX

Medical School:

MD, Baylor College of Medicine – Houston, TX

Dermatology Residency:

University of Pittsburgh – Pittsburgh, PA

Certificates
American Board of Dermatology
Publications
  • Barnes DW, Mousetis L, Amos B, and Silnutzer J Glass Bead Chromatography of Cell Attachment and Spreading Promoting Factors in Human Serum. Anal. Biochem. 127: 196-204, 1984.
  • Barnes DW, Reing JE, and Amos B. Heparin Binding Properties Of Human Serum Spreading Factor. J. Biol. Chem. 260: 9117-9122, 1985.
  • Lotan R, Lotan, D, and Amos B. Sialyltransferase in Two Melanoma Cell Lines That are Growth Inhibited by Retinoic Acid Results in Increased Sialylation of Different Cell Surface Glycoproteins. Exp. Cell Res. I 77: 284-294, 1988.
  • Amos, B. Clifford J. and Lotan R. Modulation of Melanoma Growth and Differentiation by Retinoids. Shroot 8. ed.
    “Pharmacology of Retino1ds m the Skin” S Karger, Basel· vol3: 29-36, 1989.
  • Sacks PG, Oke V, Amos B, Vasey T, and Lotan R. Modulation of Growth, Differentiation, and Glycoprotein Synthesis by P All Trans Retinoic Acid in a Multicellular Tumor Spheroid Model for Squamous Carcinoma of the Head and Neck.  Int. J Cancer 99: 926-933, 1989.
  • Amos B, Deutsch V, and Lotan R. Modulation by All Trans Retinoic Acid ofGlycosylation in Murine Melanoma Cells: Enhancement of Fucosyl and Galactosyltransferase Activities. CancerBiochem. B1ophys. 11: 31-43, 1990.
  • Amos B, Lotan D, and Lotan R. Increased Fucosylation of High Molecular Weight Glycoproteins Accompanies Retinoic Acid Differentiation ofF-9 Embryonal Carcinoma Cells. Int. J Cancer 46: 86-94, 1990.
  • Amos B and Lotan R. Modulation of Lysosomal Associated Membrane Glycoproteins (LAMPs 1 and 2) in Embryonal Carcinoma Cells Induced to Differentiate by Retinoic Acid. J. Biol. Chem. 265: 19192-19198, 1990.
  • Amos B and Lotan R. Retinoid Sensitive Cells and Cell Lines. In L. Packer (ed) Methods in Enzymology: Retinoids. Academic Press, Orlando. 190: 217-225
    Lotan R, Amos B, Watanabe H, and Raz A. Suppression ofMelanoma Cell Motility Factor Receptor Expression by Retinoic Acid. Cancer Res. 52: 4878-4884, 1992.
  • Heffernan M, Lotan R. Palcic M, Amos B, and Dennis JW. Branching of 13 l-6N-Acetylglucosamine-Transferase and Polylactosamine Expression in Mouse F-9 Teratocarcinorna Cells: Modulation During Retinoic Acid Induced Differentiation. J. Biol. Chem. 268: 1242-1251, 1993.
  • Sacks PG. Amos B, and Lotan R. Enhancement of Glycosylation of Cellular G\yconjugates in the Squamous Cell LineMDA886Ln by 13 All Trans Retinoic Acid. GlycoconjugateJ. 13: 791-796, 1996. Amos B, Deng JS, and Suarez S. Bullous Pemphlgoid in Infancy Case Report and Literature Review. Ped. Dermatol. 15: I 08-111, 1998.
  • Lu Y, Amos B, Cruise E, Lotan D, and Lotan R. A Parallel Association Between Differentiation and Induction of Galectin-1, And lnhibition of Galectin-3 by Retinoic Acid in Mouse Embryonal Carcinoma F9 Cells. Biol. Chem. 11: 1323-1331, 1998.
  • Chew J, Gin l, Rau KA, Amos B, and Bridenstine JB. Treatment of Upper Lip Wrinkles: A Comparison of950 musec Dwell Time Carbon Dioxide Laser with Unoccluded Baker’s Phenol Chemical Peel. Dermato/. Surg. 25: 262-266, 1999.
  • Gin I, Chew J, Rau KA, Amos DB, and Bridenstine JB. Treatment Of Upper Lip Wrinkles: A Comparison of950 musec Dwell Time Carbon Dioxide Laser to Manual Tumescent Dermabrasion. Dermatol. Surg. 25: 468-474, 1999.
  • Rau KA, Chew J, Gin I, Amos DB, and BridenstineJB. Treatment of Upper Lip Wrinkles: A Comparison of the Sharplan Silktouch Carbon Dioxide Laser with Ellman Radiosurgery.
    Am.Jo/CosmeticSurg. 17: 9-14,2000.